The Pharmacy Association of Saskatchewan's Annual General Meeting of the association.

1. PAS
Annual General Meeting
Saturday, May 4th, 2019
10:00 am

2. Agenda
1. Welcome from the Chair
2. Introduction of 2014-15 PAS Board
Members
 Communication of Chair and Vice-Chair
3. Business Arising from 2013 Minutes
1. Welcome from PAS Chair 2. Approval of AGM 2019 Agenda.
3. Introduction of 2019-2020 PAS Board
Members
• Chair/Vice-Chair Announcement
• CPhA Board Representative
4. Motion to Accept 2018 Minutes as printed
and distributed
5. Business Arising from 2018 Minutes 6. Financial Matters
• Approval of 2017-18 Audited Financial
Statements
• Appointment of PAS Auditor
7.Reports
• Chair’s Report
• CEO’s Report
• Director of Professional Practice Report
• CPhA Representative Report
• Committee Reports (in Annual Reports)
8. New Business
9. Adjournment

3. Motion to Approve 2019 PAS
AGM Agenda

4. Announcement of PAS 2019-2020
Board of Directors
John Stanzeleit (Chair) George Furneaux (Vice-Chair)
Paul Bazin (Past Chair) Amy Lamb
Warren Delmage Lindsey Ziegler
Monique Swack Robyn Despins
Cordell Hilderman
Dr. Kishor Wasan, Dean, College of
Pharmacy and Nutrition (until July
2019)
Laura Almas CSHP – SK Branch
Palima Shrestha, Senior Stick
Student Representative (until
Sept. 1)
Christine Hrudka – CPhA Board
Representative
Elected Members:
Appointed Members:

5. Motion to approve 2018
AGM Minutes as distributed

6. Business Arising from
2018 Minutes

7. Financial Matters
 Approval of the 2017-18 Audited Financial
Statements (Meyers, Norris and Penney)
contained within the new PAS Annual Report (on
tables)
 Appointment of Auditor (recommending Meyers,
Norris and Penney)

8.  Highlights:
 membership numbers stayed relatively consistent with incremental
growth in 2017-18.
 Excess of revenues over expenses: $71,400 (6% of total
revenues)
 Operating expenses increased by $56,833 (6%) primarily due to
advocacy, issues mgmt, and public education initiatives approved
by Board but also additional transition costs on building occupancy
between old office and new, and increased salary costs.
 Staffing and Benefits largest portion of costs: approximately 41%
of overall costs ($468,429)
 Board directed transfer of cumulative operational surpluses to
investments account (emergency fund) so account now just over
500K
2017-18 Audited Statements

9. Motion to approve 2017-18
statements as presented and
provided
Approval of Financial Statements

10. Recommending re-appointment of Meyers,
Norris, Penney as PAS Auditor for 2018-19
fiscal year.
(motion to re-appoint)
Appointment of Auditor

11. Reports
 PAS Chair Report
 CEO’s Report
 Director of Professional Practice’s Report
 CPhA Representative Report
 Current Year Committee Reports
* More detailed reports are in the printed annual
reports

12. Highlights:
 Continued pressures on the pharmacy business model. Generic pricing agreement, wholesalers agreement,
e-prescribing push, regulatory changes, third-party pressures, and more.
 New contract finalized in October 2018 – although best in Canada at the time, more work to be done on pharmacist
role and financial enablers.
 Advocacy Initiatives: PAS continues to bring pharmacist voice to tables including regulatory tables, PrescribeIT,
third party payors (through national 3rd party payor working group), physicians, and others.
 Public Education: reduced but significant flu shot and minor ailment campaigns but also new this year, PAS utilized
public education “Rethink Pharmacists” campaign this year during PAM. This was the first time many provinces ran a
collective campaign using the same tools. Creates a national look to some advocacy/public education.
 Continued change is the only constant: National Pharmacare, continued economic pressures, practice change
(eg. Travel health), regulatory changes, ….
The PAS Board and Staff are working hard for you – make sure you stay connected by having a membership!
Report from the Chair

13. Highlights:
• Working with the PAS Economics Committee, we have had sustained advocacy and preparation work for pharmacy
contract negotiations which culminated in the new one-year contract. Also worked with federal government to match
new professional fee. We have begun the process again and will begin meetings before summer.
• Providing feedback to SCPP regarding scope of practice and proposed regulatory changes. SCPP continues to
collaborate with PAS to enable feedback on important initiatives.
• Public education campaigns on flu shots and minor ailments and generalized campaign “Health care in Saskatchewan
needs to see a pharmacist”
• Responding (again) to physician actions related to concerns on new self-care/minor ailments.
• Renewed planning and risk identification and management for the Association. Some disturbing trends with reducing
membership are predicted.
• Multitude of small and large initiatives to manage, including flu vaccine supply management, new SCA PACT
partnership, SMAP audit communications, and provincial and national media and policy issues.
Report from the CEO

14. Provincial Flu Vaccination Program
 First year of Expanded program:
 home visits and congregate living
 Reduced mobility/access (excluding LTC homes)
 patients age 5 and up (in-line with Bylaws for injecting)
 As of February March 31, 2019, 154,892 flu shots administered (last year 118,050)
 Up 32% from 2017-18
 Up 71% from 2016-17
 Up 178% from 2015-16
 Reminders: All reports are to be sent in immediately
 Notification of Vaccine Administration, Product Wastage, Cold Chain, AEFI, Vaccine supply problem
Travel Health and Vaccinations
 Collaborating with SCPP, Ministry, DPEBB, CPDPP at various stages throughout the process
PACT
 Created a partnership with Saskatchewan Cancer Agency (SCA)
 Referring patients requiring PACT counseling and/or tobacco cessation prescribing to community PACT pharmacists
 Updating several modules including Oncology, Quitting Commercial Tobacco, Youth
 Training now housed at CPDPP
 PACT website migration to PAS website underway
Report from the Director of
Professional Practice

15. Minor Ailment Expansion*
Injection Administration Fee- New*
 Medroxyprogesterone actetate injectable suspension 150mg/ml
Total Billable Services $9,750,282 ($8,784,282 in 2017-18)
 Minor ailments $501,647 ($300,635)
 Influenza Immunization Fee $2,033,356 ($1,531,996)
 Injection Administration Fee $14,639 (N/A)
Pharmacy Professional Services
Fiscal 2018-19
DPEBB Fiscal Year April 1- March 31
*Starting Nov 1
**Starting Dec 6
Conjuctivitis Obesity
Emergency Contraception Onychomycosis
Erectile Dysfunction Shingles
Hormonal Contraception Uncomplicated UTI
Influenza Tobacco Cessation**

16. In the Annual Report, more details on the following:
 Expanded Influenza program support documents and communications
 Guide for Vaccine Screening Tool and Consent form Questions and Guide
 Minor Ailment, Self-care and Preventable Disease support material
 NIHB Pharmacists Initiated Treatment document
 National Third Party Payor Working Group
 Work of the Professional Practice Committee
 Collaboration with the DPEBB on improving the SMAP program
 Student support
 Saskatchewan Health Authority collaboration on Discharge/Transfer forms
Report from the Director of
Professional Practice

17. Report from CPhA Board
Representative (Christine Hrudka)
CPhA Report

18. 2018 YEAR IN
REVIEW
Pharmacy Association of Saskatchewan
Annual General Meeting

19. Mission, Vision & Strategic Plan 2017-
2020

20. Advocate for Pharmacists

21. Advance the profession

22. Ensure financial capacity

23. Delivering member value

24. New initiative

25. Stronger Together

26. Written Committee Reports
from Economics and
Professional Practice
Committees in Annual Report
on tables
Committee Reports

27. Any New Business?

28. Adjournment
Motion for Adjournment
If no questions, PAS AGM 2019 is adjourned.
Thank you for participating.